First Patient Enrolled In Thrombolex's RESCUE II Study – On-Table Pharmacomechanical Lysis Without Post-Procedural Infusion

Thrombolex, Inc. announced the enrollment of the first patient in the RESCUE II study using the BASHIR™ Endovascular Catheter for the treatment of acute...

Related Keywords

New Britain ,Pennsylvania ,United States ,Philadelphia ,Temple University Hospital ,Brian Firth ,Riyaz Bashir ,Vladimir Lakhter ,Thrombolex Inc ,Endovascular Catheter ,Parth Rali ,Associate Professor ,Thoracic Medicine ,Lewis Katz School ,Temple University ,More Information ,Chief Scientific Officer ,